For the quarter ending 2026-03-31, TNGX has $435,792K in assets. $44,286K in debts. $157,828K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 157,828 | 112,279 | 58,338 | 39,272 |
| Marketable securities | 222,011 | 230,859 | 94,473 | 141,513 |
| Restricted cash | 0 | 428 | 428 | 428 |
| Prepaid expenses and other current assets | 12,488 | 10,190 | 10,540 | 8,887 |
| Total current assets | 392,327 | 353,756 | 163,779 | 190,100 |
| Property, plant and equipment, gross | 17,322 | 17,406 | 17,406 | 17,396 |
| Less accumulated depreciation | 10,941 | 10,538 | 10,060 | 9,610 |
| Property and equipment, net | 6,381 | 6,868 | 7,346 | 7,786 |
| Operating leaseright-of-useassets | 34,652 | 35,624 | 36,582 | 37,555 |
| Restricted cash, net of current portion | 2,139 | 2,139 | 2,139 | 2,139 |
| Other assets | 293 | 303 | 290 | 310 |
| Total assets | 435,792 | 398,690 | 210,136 | 237,890 |
| Accounts payable | 2,430 | 1,182 | 2,229 | 2,607 |
| Accrued expenses and other current liabilities | 9,068 | 17,759 | 13,113 | 11,510 |
| Operating lease liabilities | 2,832 | 2,738 | 3,102 | 2,534 |
| Deferred revenue | - | 0 | 0 | 23,374 |
| Total current liabilities | 14,330 | 21,679 | 18,444 | 40,025 |
| Operating lease liabilities, net of current portion | 29,956 | 30,832 | 31,661 | 32,474 |
| Deferred revenue, net of current portion | - | 0 | 0 | 30,437 |
| Total liabilities | 44,286 | 52,511 | 50,105 | 102,936 |
| Common stock, 0.001 par value 400,000,000 and 200,000,000 shares authorized at march 31, 2026 and december 31, 2025, respectively 144,162,543 and 135,940,454 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 144 | 136 | 112 | 111 |
| Additionalpaid-incapital | 1,040,143 | 948,971 | 724,201 | 715,036 |
| Accumulated other comprehensive (loss) income | -115 | 224 | 121 | 94 |
| Accumulated deficit | -648,666 | -603,152 | -564,403 | -580,287 |
| Total stockholders' equity | 391,506 | 346,179 | 160,031 | 134,954 |
| Total liabilities and stockholders' equity | 435,792 | 398,690 | 210,136 | 237,890 |
Tango Therapeutics, Inc. (TNGX)
Tango Therapeutics, Inc. (TNGX)